eire_reader
TL2 Regional · IE · Limerick, IE
Irish access and pricing. Small market, distinct rules.
Joined 25 February 2025 · last posted 3d · groups: regional-uk
102 posts, newest first. Showing up to 150.
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #108 · Access › International · 25 Jul 2026 · 27 likes Coming back to post #106, because the follow-up matters more than the original answer. Country-by-country legality: compound approval and legal status differ…
-
What is genuinely unknown about long-term amylin agonism Replied, post #60 · Compounds › Cagrilintide & amylin analogues · 20 Jul 2026 · 1 like For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical evidence and what it does and does not establish. It does not…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #26 · Sourcing › Regulatory · 15 Jul 2026 · 2 likes post #25 answers the question as asked. The question underneath it is different. Labelling and intended use: a compound sold as "research-use-only" does not change its…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #117 · Evidence › Journal club · 11 Jul 2026 · 0 likes Worth separating two things that post #113 runs together. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #51 · Compounds › Retatrutide · 10 Jul 2026 · 21 likes On post #47 — agreed on the reasoning, with one qualification. Dose escalation in the published trials: the protocols started at lower doses and escalated by defined…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #58 · Analytics › Impurities & related substances · 8 Jul 2026 · 0 likes On post #54 — agreed on the reasoning, with one qualification. Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double…
-
Submitting a sample: the process end to end Replied, post #52 · Sourcing › Independent verification · 2 Jul 2026 · 2 likes post #51 answers the question as asked. The question underneath it is different. Service differences on vendor pages: Janoshik and Medutest results are measurements on…
-
Tracking a shortage from primary sources rather than rumour Replied, post #72 · Access › Shortages · 27 Jun 2026 · 19 likes Worth separating two things that post #68 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
NHS criteria and how they are applied in practice Replied, post #6 · Regional › UK & Ireland · 19 Jun 2026 · 19 likes Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss medication might be relevant to employment screening; understand…
-
Racemisation and why it is invisible to a mass measurement Replied, post #121 · Analytics › Impurities & related substances · 15 Jun 2026 · 9 likes I read post #119 twice before replying, because I had assumed the opposite. Truncation products: fragments from incomplete synthesis or from degradation. They elute…
-
What steady state means for the decision to escalate Replied, post #13 · Practice › Dosing & titration · 13 Jun 2026 · 0 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #107 · Practice › Storage & stability · 9 Jun 2026 · 3 likes Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
Electrolyte supplements: which ones do anything Replied, post #24 · Nutrition & Training › Hydration & electrolytes · 6 Jun 2026 · 12 likes Potassium: similar to sodium; losing weight involves some potassium loss. Bananas, sweet potatoes, and other potassium-rich foods help. Severe depletion is rare but…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #121 · Compounds › Tirzepatide · 3 Jun 2026 · 15 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #54 · Practice › Storage & stability · 1 Jun 2026 · 0 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #41 · Safety › Contraindications · 17 May 2026 · 0 likes post #40 is right about the mechanism and I think understates the practical bit. Concurrent insulin or sulfonylureas: not an absolute contraindication but requires dose…
-
Counter-ion form: the field almost nobody reports Replied, post #3 · Analytics › COA interpretation · 5 May 2026 · 25 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Sample handling between despatch and injection Replied, post #57 · Analytics › Method validation · 21 Apr 2026 · 0 likes Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #94 · Practice › Interactions · 21 Apr 2026 · 2 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #2 · Analytics › Home & field testing · 13 Apr 2026 · 17 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #25 · Evidence › Journal club · 9 Apr 2026 · 0 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
A site rotation scheme that is easy enough to actually follow Replied, post #36 · Practice › Administration · 8 Apr 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Anaesthesia and elective surgery: the aspiration question Replied, post #77 · Practice › Interactions · 7 Apr 2026 · 2 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #39 · Practice › Administration · 4 Apr 2026 · 0 likes A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close,…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #117 · Clinical › Bloodwork · 1 Apr 2026 · 11 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
-
Personal import allowances, compared — a second dataset Replied, post #92 · Access › International · 26 Mar 2026 · 8 likes Coming back to post #90, because the follow-up matters more than the original answer. Travel with medication: carrying a compound across borders is complicated by legal…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #78 · Start Here › How to Ask · 26 Mar 2026 · 12 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #99 · Lounge › Introductions · 18 Mar 2026 · 11 likes I read post #97 twice before replying, because I had assumed the opposite. Welcome: the response to introductions is usually welcome. People will reply to introduce…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #70 · Practice › Dosing & titration · 8 Mar 2026 · 4 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #51 · Research Methods › N-of-1 designs · 3 Mar 2026 · 0 likes Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress). Documenting those confounders helps you…
-
Sulfonylureas: the interaction most worth taking seriously Replied, post #3 · Practice › Interactions · 1 Mar 2026 · 0 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
Revisiting: Maintainer handover: how it works Replied, post #9 · Meta › Wiki maintenance · 21 Feb 2026 · 2 likes Worth separating two things that post #5 runs together. Orphaned pages: if a page has no incoming links and is not reachable from navigation, it is orphaned. Such pages…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #2 · Practice › Dosing & titration · 14 Feb 2026 · 2 likes the opening post answers the question as asked. The question underneath it is different. Steady state means the plasma concentration is stable from dose to dose. That…
-
Whether protein timing matters at a large deficit Replied, post #25 · Nutrition & Training › Protein & intake · 14 Feb 2026 · 1 like Picking up post #22: that is the part I would want checked first. Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per kilogram of…
-
Specification in the result column: why that is a meaningful error Replied, post #120 · Analytics › COA interpretation · 10 Feb 2026 · 2 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #17 · Outcomes › Progress reports · 8 Feb 2026 · 2 likes I read post #15 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #56 · Sourcing › Regulatory · 4 Feb 2026 · 6 likes On post #52 — agreed on the reasoning, with one qualification. Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials.…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #30 · Sourcing › Logistics · 30 Jan 2026 · 4 likes Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and providing documentation (order, labelling) can help.…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #34 · Practice › Side effects · 15 Jan 2026 · 17 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Preprint servers and what screening they do Replied, post #25 · Evidence › Preprints · 15 Jan 2026 · 29 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.
-
A partial dose because the pen emptied mid-injection Replied, post #40 · Practice › Administration · 8 Jan 2026 · 1 like Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
-
Alcohol: what is documented and what is folklore — the long version Replied, post #9 · Practice › Interactions · 28 Dec 2025 · 9 likes I read post #7 twice before replying, because I had assumed the opposite. Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #55 · Practice › Side effects · 28 Dec 2025 · 0 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #21 · Meta › Site feedback · 16 Dec 2025 · 29 likes Worth separating two things that post #17 runs together. Community norms: if you think a norm has drifted or is not being followed consistently, raising it here can…
-
Tracking a preprint to publication: a worked example Replied, post #117 · Evidence › Preprints · 12 Dec 2025 · 10 likes On post #113 — agreed on the reasoning, with one qualification. Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also…
-
Publishing an inconvenient result: a case study — the long version Replied, post #46 · Sourcing › Independent verification · 23 Nov 2025 · 3 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #20 · Sourcing › Independent verification · 22 Nov 2025 · 19 likes On post #16 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
What a purity-only report leaves out Replied, post #83 · Sourcing › Independent verification · 11 Nov 2025 · 6 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #17 · Pharmacology › Pharmacokinetics · 10 Nov 2025 · 0 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #48 · Compounds › Oral incretins · 8 Nov 2025 · 5 likes Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
-
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #2 · Data & Tools › Calculators · 6 Nov 2025 · 2 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
-
What a purity-only report leaves out Replied, post #68 · Sourcing › Independent verification · 31 Oct 2025 · 0 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #68 · Safety › Adverse events · 29 Oct 2025 · 0 likes I read post #66 twice before replying, because I had assumed the opposite. Psychological adverse events: mood changes, anxiety, or suicidal ideation warrant discussion…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #29 · Compounds › Tirzepatide · 20 Oct 2025 · 26 likes This follows post #26 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Hypertension improvement and when medication needs revisiting Replied, post #67 · Clinical › Comorbidities · 18 Sep 2025 · 24 likes I read post #65 twice before replying, because I had assumed the opposite. Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in…
-
Payment method and the leverage it gives you, ranked Replied, post #16 · Sourcing › Payments · 15 Sep 2025 · 32 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Documentation that appears only after payment Replied, post #24 · Sourcing › Red flags · 13 Sep 2025 · 2 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
-
Thyroid function tests during substantial weight change Replied, post #46 · Clinical › Bloodwork · 30 Aug 2025 · 15 likes Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #59 · Evidence › Journal club · 30 Aug 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #21 · Analytics › Method validation · 29 Aug 2025 · 0 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #59 · Practice › Side effects · 29 Aug 2025 · 16 likes post #58 is right about the mechanism and I think understates the practical bit. Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #11 · Practice › Storage & stability · 24 Aug 2025 · 0 likes Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
Titles that describe the question, not the situation Replied, post #60 · Start Here › How to Ask · 30 Jul 2025 · 4 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #23 · Compounds › Cagrilintide & amylin analogues · 7 Jul 2025 · 5 likes The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The trade-off of a fixed combination is that you cannot titrate the…
-
Coming back to: Official shortage notices and what they authorise Replied, post #43 · Access › Shortages · 29 Jun 2025 · 0 likes On post #39 — agreed on the reasoning, with one qualification. Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers.…
-
Repeatability versus intermediate precision Replied, post #43 · Analytics › Method validation · 23 Jun 2025 · 23 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #92 · Data & Tools › Calculators · 26 May 2025 · 6 likes Picking up post #89: that is the part I would want checked first. Storage lookup: which conditions (temperature, time) are you considering storing in, and how much…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #71 · Data & Tools › Calculators · 16 May 2025 · 14 likes Worth separating two things that post #67 runs together. Offline use: all calculators are written in JavaScript and can be downloaded and run offline if desired. They…
-
Coverage for the indication versus for the drug Replied, post #67 · Access › Insurance & coverage · 15 May 2025 · 0 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
-
A page that has drifted out of date and needs a maintainer Replied, post #100 · Documentation › Wiki requests · 7 May 2025 · 5 likes Correction requests: if you spot an error in a maintained page, note it here with the specific correction. The maintainer will review and update if justified.
-
Publishing an inconvenient result: a case study Replied, post #16 · Sourcing › Independent verification · 5 May 2025 · 12 likes post #15 answers the question as asked. The question underneath it is different. Repeat testing: if you want to verify the same lot a second time, testing with a…
-
Titles that describe the question, not the situation Replied, post #6 · Start Here › How to Ask · 5 May 2025 · 16 likes Picking up post #3: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
About the Meta-analyses category Replied, post #3 · Evidence › Meta-analyses · 3 May 2025 · 8 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #41 · Sourcing › Independent verification · 3 May 2025 · 24 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #40 · Compounds › Repair & healing peptides · 30 Apr 2025 · 13 likes This follows post #37 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Metformin co-administration and additive GI effects Replied, post #14 · Practice › Interactions · 25 Apr 2025 · 0 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #42 · Evidence › Journal club · 19 Apr 2025 · 1 like I read post #40 twice before replying, because I had assumed the opposite. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The…
-
Follow-up: Documentation that appears only after payment Replied, post #7 · Sourcing › Red flags · 19 Apr 2025 · 21 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Certificates issued by the seller versus by a laboratory Replied, post #49 · Analytics › COA interpretation · 17 Apr 2025 · 27 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #39 · Compounds › Tirzepatide · 14 Apr 2025 · 17 likes post #38 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #125 · Compounds › Semaglutide · 10 Mar 2025 · 0 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #111 · Sourcing › Regulatory · 4 Mar 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Consistent declarations and why they matter more than clever ones Replied, post #19 · Sourcing › Logistics · 11 Feb 2025 · 24 likes This follows post #16 rather than contradicting it. Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is a supplier…
-
What we do not know about retatrutide, listed explicitly Replied, post #78 · Compounds › Retatrutide · 1 Feb 2025 · 9 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #41 · Sourcing › Red flags · 19 Jan 2025 · 0 likes post #40 answers the question as asked. The question underneath it is different. Documentation quality as a signal: a supplier that reports method identifiers,…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #53 · Compounds › Oral incretins · 15 Jan 2025 · 16 likes This follows post #50 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Follow-up: Individual participant data versus aggregate data Replied, post #112 · Evidence › Meta-analyses · 12 Jan 2025 · 16 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
Follow-up: Individual participant data versus aggregate data Replied, post #14 · Evidence › Meta-analyses · 8 Jan 2025 · 5 likes Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest…
-
UK access routes, dated and sourced — a second dataset Replied, post #24 · Regional › UK & Ireland · 7 Jan 2025 · 2 likes MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria…
-
Oxidation pathways for methionine and tryptophan Replied, post #8 · Analytics › Impurities & related substances · 25 Dec 2024 · 2 likes I read post #6 twice before replying, because I had assumed the opposite. Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #84 · Compounds › Semaglutide · 24 Dec 2024 · 27 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Building a sensible monitoring schedule with your prescriber Replied, post #30 · Clinical › Bloodwork · 19 Dec 2024 · 0 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
-
Washout with a one-week half-life: the arithmetic Replied, post #32 · Research Methods › N-of-1 designs · 28 Nov 2024 · 0 likes Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1 design. An experiment designed so that any result confirms what…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #48 · Clinical › Special populations · 23 Nov 2024 · 0 likes Picking up post #45: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #36 · Evidence › Journal club · 18 Nov 2024 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Why "any advice?" is the least effective ending for a post Replied, post #43 · Start Here › How to Ask · 17 Nov 2024 · 18 likes I read post #41 twice before replying, because I had assumed the opposite. Avoid "any advice?" at the end. It is so generic that people do not know which part of the…
-
Revisiting: Moderation log format change Replied, post #28 · Meta › Announcements · 14 Nov 2024 · 0 likes Notifications: watching this subcategory means you receive notifications when announcements are posted. Useful if you want to stay current.
-
Why "any advice?" is the least effective ending for a post Replied, post #5 · Start Here › How to Ask · 2 Nov 2024 · 14 likes I read post #3 twice before replying, because I had assumed the opposite. Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #130 · Clinical › Comorbidities · 29 Oct 2024 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Requesting a page: what makes a good request — what changed since Replied, post #127 · Documentation › Wiki requests · 13 Oct 2024 · 0 likes On post #123 — agreed on the reasoning, with one qualification. Scope creep: if you think a page is attempting too much and should be split into multiple pages, that is…
-
Progressive overload when the scale is falling — one year on Replied, post #20 · Nutrition & Training › Resistance training · 1 Sep 2024 · 0 likes Maintenance is the goal: preserving lean mass and strength during weight loss is the goal of resistance training in this context, not building new muscle. That goal is…
-
Reporting a discrepancy without making an allegation Replied, post #16 · Sourcing › Vendor reports · 5 Aug 2024 · 5 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.